Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

June 30, 2018

Conditions
Clostridium Difficile
Interventions
DRUG

Fecal Microbiota Preparation

Frozen processed human fecal material for treating recurrent Clostridium difficile infections.

Trial Locations (4)

46202

IU University Hospital, Indianapolis

60540

Edward Hospital, Naperville

02108

Tufts Medical Center, Boston

02904

Brown University, Providence

All Listed Sponsors
collaborator

Brown University

OTHER

collaborator

Edward Hospital

OTHER

collaborator

Indiana University

OTHER

collaborator

Tufts Medical Center

OTHER

lead

Microbiome Health Research Institute

OTHER